Month: September 2020

Novo Reaches First Completion Milestone With Creasy Group, Expands Operations Team, and Presents at 2020 Precious Metals Summit – Beaver Creek

Written by Customer Service on September 15, 2020. Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has reached first completion with respect to its previously announced binding terms sheet (the “Terms Sheet”) with Mark Creasy and entities controlled by him (collectively, the “Creasy Group”) and issued 2,582,269 common shares (the “First Completion Shares”) of the Company to the Creasy Group (for further details, please see the Company’s news release dated June 15, 2020). The First Completion Shares are subject to a statutory hold period expiring on January 15, 2021.Immediately subsequent to the issuance of the First Completion Shares, the Creasy Group held 6.46% of the issued and outstanding shares of the Company.The Company will issue an additional 8,431 common...

CF Energy Expands Electric Vehicle (EV) BatterySwap Services in Haikou and Zhuhai

Written by Customer Service on September 15, 2020. Posted in Public Companies.

TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — CF Energy Corp. (TSX-V: CFY) (“CF Energy” or the “Company”, together with its subsidiaries, the “Group”), a leading new energy service provider in the People’s Republic of China (the ”PRC” or “China”) is pleased to announce that the Company and EDF (China) Holding Ltd. (“EDF (China)”), a wholly owned subsidiary of the EDF Group, have signed an 8 year exclusive co-operating agreement with BAIC Qingxiang Technology Co., Ltd. (“BAIC QX”) and Blue Valley Smart (Beijing) Energy Technology Co., Ltd. (“Blue Valley”) (collectively the “JV Partners”) to provide Electric Vehicle (“EV”) battery swap services in the city of Haikou, capital of Hainan Province. On the same day, a memorandum of understanding was also signed among the Company, EDF (China) and Blue Valley (collectively the “MOU Parties”)...

OptimizeRx Expands Direct-to-Patient Reach, Partnering with Epion Health to Provide Adherence and Affordability Support at Point-of-Care

Written by Customer Service on September 15, 2020. Posted in Public Companies.

Patients Gain Direct Access to Financial Assistance Relevant to Their Health Journey Prior to Their Medical AppointmentROCHESTER, Mich., Sept. 15, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has partnered with Epion Health, a leader in digital patient engagement solutions, to give patients direct access to savings programs sponsored by life science companies.Patients at health systems and medical groups across the nation using Epion’s recently announced Epion Patient Services™ – a feature of its digital check-in solution, Epion Check-In™ – will gain access to the OptimizeRx digital health and communications platform to receive available savings offers.According to the Annals of Internal Medicine, patients and physicians...

francesca’s® Reports Second Quarter Fiscal Year 2020 Financial Results and Announces Exploration of Strategic Alternatives

Written by Customer Service on September 15, 2020. Posted in Earnings Releases And Operating Results.

HOUSTON, Sept. 15, 2020 (GLOBE NEWSWIRE) — Francesca’s Holdings Corporation (Nasdaq: FRAN) today reports financial results for the second quarter ended August 1, 2020 and announced exploration of strategic initiatives. Second Quarter Highlights:Net sales decreased 29% to $75.7 millionComparable sales decreased 5% (1)Diluted loss per share was $5.80 compared to diluted earnings per share of $0.61 in the same period last yearContinued to take aggressive and prudent actions to reduce expense and manage cash flowsReduced clearance inventory by 45% compared to the same period last year(1) Comparable sales for the thirteen weeks ended August 1, 2020 excludes boutique sales during the weeks in which a boutique was temporarily closed for four or more days of a week due to the COVID-19 pandemic and includes ecommerce sales for the full thirteen...

Captor Capital Reports Revenues of $12.5 Million and Gross Profit from Retail Operations of $3.4 Million in Annual Audited Financial Statements for the Year Ended March 31, 2020

Written by Customer Service on September 15, 2020. Posted in Earnings Releases And Operating Results.

2020 annual revenue of $12.5 million vs. 2019 annual revenue of $5.9 million2020 Annual gross profit of $3.4 million vs. 2019 gross profit of $1.6 millionTORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; FRANKFURT: NMV; STUTTGART: NMVA; USOTC: CPTRF), (“Captor” or the “Company”), The Company is pleased to announce today the release of its Annual Audited Financial statements and MD&A for the Year Ended March 31, 2020. During the year, revenues at the Company’s two Chai Cannabis Co. dispensaries were approximately $12.5 million. Gross profit during the same period was approximately $3.4 million.Management CommentaryIn the midst of an unprecedented and extremely challenging retail landscape, the Company has implemented processes to increase focus on profitability and disciplined...

Kaival Brands Increases Revenues Nearly 44%, Expands Distribution Channels

Written by Customer Service on September 15, 2020. Posted in Earnings Releases And Operating Results.

GRANT, Fla., Sept. 15, 2020 (GLOBE NEWSWIRE) — via NetworkWire – Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) (“Kaival Brands,” the “Company” or “we”), a company focused on growing and incubating innovative and profitable products into mature, dominant brands, announces an increasing demand for the Bidi™ Stick is driving sales to new heights. Financial results for the Company’s 2020 third quarter, ended July 31, show revenues increased approximately 44% compared to the second quarter of 2020, with total revenues for the first nine months of the year reaching nearly $54.9 million.“We had an extremely busy and fruitful third fiscal quarter. We experienced a rising demand for our exclusively distributed premium product, the Bidi™ Stick. Our sales growth is occurring mostly organically through smaller distribution channels...

Cowen to Acquire Investment Banking Business of MHT Partners, Further Deepening Coverage of Middle-Market and Private Equity Investors

Written by Customer Service on September 15, 2020. Posted in Mergers And Acquisitions.

NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ: COWN) (“Cowen” or the “Company”) today announced that it has signed a definitive agreement to acquire substantially all of the assets of MHT Partners, LP (“MHT Partners”), an investment bank focused on representing innovative companies in growing markets. Based primarily in Dallas and San Francisco, MHT Partners’ investment banking team is expected to join Cowen under the agreement. Terms of the acquisition, which is not material to Cowen from a financial perspective, were not disclosed.“Cowen’s momentum in investment banking reflects our commitment to serving the dynamic companies that fuel the global economy. Accelerating that strategy, we welcome MHT Partners’ impressive banking team to the Cowen platform,” said Larry Wieseneck, Co-President of Cowen and Company....

Aptose to Present at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Written by Customer Service on September 15, 2020. Posted in Public Companies.

SAN DIEGO and TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today announced that William G. Rice, Ph.D., Chairman, President and Chief Executive Officer, and the Aptose management team will participate at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit:Oppenheimer Fall Healthcare Life Sciences & Medtech SummitThe audio webcast can also be accessed through the Aptose website at www.aptose.com and will be archived shortly after the live events.About AptoseAptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology, with an initial focus on hematology. The...

IPG and Pacira BioSciences Announce Collaboration to Reduce Postsurgical Opioid Prescribing and Surgical Procedure Costs

Written by Customer Service on September 15, 2020. Posted in Public Companies.

ALPHARETTA, Ga. and PARSIPPANY, N.J., Sept. 15, 2020 (GLOBE NEWSWIRE) — IPG, the industry-leading provider of surgical cost management solutions, and Pacira BioSciences, Inc. (NADSAQ: PCRX), a leading provider of non-opioid pain management options, today announced a collaboration to reduce postsurgical opioid prescribing and surgical procedure costs across the IPG national health plan and provider network.Through this partnership, IPG will offer reimbursement for EXPAREL® (bupivacaine liposome injectable suspension) to its health plan provider clients across the country to further support its mission to bring high quality, cost-effective surgical solutions to the U.S. healthcare market. Pacira will work alongside IPG to provide education and training to ensure consistent, positive outcomes are achieved across procedures, clinicians,...

Wave Life Sciences to Highlight Preclinical ADAR Editing Data and Neurology Programs at TIDES and OTS Annual Meetings

Written by Customer Service on September 15, 2020. Posted in Public Companies.

CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that it will highlight its ADAR (adenosine deaminases acting on RNA)-mediated RNA editing technology (“ADAR editing”) and its neurology programs in Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) at upcoming conferences, including the TIDES: Oligonucleotide and Peptide Therapeutics 2020 meeting and the 16th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS), taking place on September 15-18, 2020 and September 27-30, 2020, respectively.At TIDES and OTS, Wave will share how it is developing ADAR editing as a potentially best-in-class...

Month: September 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals